Riskpilot← Back to searchSign inGet full accessGYN AS
ASActiveOrg 892898162Gamle Tuddalsveg 12, 3692 SaulandMedical specialists activities · NACE 8622Est. 20080 employees
Revenue 2022
NOK 671K
-5% vs 2021
EBITDA margin
19.7%
-38% vs 2021
Equity ratio
39.5%
Financial strength
Net profit 2022
NOK 103K
-39% vs 2021
| Revenue | NOK 671K | -5% |
| EBITDA | NOK 132K | -38% |
| Net profit | NOK 103K | -39% |
| Total assets | NOK 1,7M | +6% |
| Equity | NOK 656K | +0% |
| Employees | 0 | — |
Legal name
GYN AS
Org number
892898162
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
23. juli 2008
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Selv, gjennom hel- eller deleide selskaper eller ved samarbeide med andre virksomheter, kjøp, drift, utvikling og utleie av fast eiendom samt hva hermed står i forbindelse.
Address
Gamle Tuddalsveg 12, 3692 Sauland
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 1 430 | 1 379 | 1 288 | 706 | 671 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 933 | 860 | 801 | 213 | 132 |
| Depreciation & amort. | −15 | −15 | −5 | −0 | −0 |
| EBIT | 918 | 845 | 796 | 213 | 132 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 918 | 845 | 796 | 213 | 132 |
| Tax | 211 | 187 | 172 | 45 | 29 |
| Net profit | 707 | 658 | 624 | 169 | 103 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 1 731 | 1 835 | 1 952 | 1 562 | 1 661 |
| Equity | 637 | 632 | 645 | 656 | 656 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 094 | 1 204 | 1 307 | 907 | 1 006 |
| Total debt | 1 094 | 1 204 | 1 307 | 907 | 1 006 |
EBITDA margin
19.7%
This company
15.8%
Market median
+25% vs market
20182022
Equity ratio
39.5%
This company
38.2%
Market median
+3% vs market
20182022
Return on equity
15.7%
This company
18.4%
Market median
+15% vs market
20182022
Net profit margin
15.3%
This company
8.1%
Market median
+89% vs market
20182022
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20182022
Debt / equity
1.53×
This company
0.62×
Market median
-147% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AF Deputy Member | Deputy Member | 2008 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2008 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mimose As
GYN AS Board members of GYN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aase Fjeld | Deputy Member | 0 companies |
| Roar Marthinius Fjeld | Chairman | 0 companies |